Literature DB >> 19762375

Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and Portugal.

B A Pons-Estel1, J Sánchez-Guerrero, J Romero-Díaz, A Iglesias-Gamarra, E Bonfa, E F Borba, S K Shinjo, S Bernatsky, A Clarke, M A García, J C Marcos, A Duarte, G A Berbotto, H Scherbarth, C D Marques, L Onetti, V Saurit, A W S Souza, E Velozo, L J Catoggio, O Neira, P I Burgos, L A Ramirez, J F Molina, I G De La Torre, R Silvariño, J A Manni, S Durán-Barragán, L M Vilá, P R Fortin, J Calvo-Alén, M J Santos, M Portela, M H Esteva-Spinetti, M Weisman, E M Acevedo, M I Segami, S B Gentiletti, J Roldán, I Navarro, E Gonzalez, J M Liu, E W Karlson, K H Costenbader, F Wolfe, G S Alarcón.   

Abstract

We have previously developed and validated a self-administered questionnaire, modelled after the Systemic Lupus International Collaborating Clinics Damage Index (SDI), the Lupus Damage Index Questionnaire (LDIQ), which may allow the ascertainment of this construct in systemic lupus erythematosus (SLE) patients followed in the community and thus expand observations made about damage. We have now translated, back-translated and adapted the LDIQ to Spanish, Portuguese and French and applied it to patients followed at academic and non-academic centres in North and South America, Portugal and Spain while their physicians scored the SDI. A total of 887 patients (659 Spanish-speaking, 140 Portuguese-speaking and 80 French-speaking patients) and 40 physicians participated. Overall, patients scored all LDIQ versions higher than their physicians (total score and all domains). Infrequent manifestations had less optimal clinimetric properties but overall agreement was more than 95% for the majority of items. Higher correlations were observed among the Spanish-speaking patients than the Portuguese-speaking and French-speaking patients; further adjustments may be needed before the Portuguese and French versions of the LDIQ are applied in community-based studies. The relationship between the LDIQ and other outcome parameters is currently being investigated in a different patient sample.

Entities:  

Mesh:

Year:  2009        PMID: 19762375      PMCID: PMC2933049          DOI: 10.1177/0961203309105590

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  14 in total

1.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

2.  Damage in systemic lupus erythematosus and its association with corticosteroids.

Authors:  A Zonana-Nacach; S G Barr; L S Magder; M Petri
Journal:  Arthritis Rheum       Date:  2000-08

3.  The rate and pattern of organ damage in late onset systemic lupus erythematosus.

Authors:  Peter Maddison; Vernon Farewell; David Isenberg; Cynthia Aranow; Sang-Cheol Bae; Susan Barr; Jill Buyon; Paul Fortin; Ellen Ginzler; Dafna Gladman; John Hanly; Susan Manzi; Ola Nived; Michelle Petri; Rosalind Ramsey-Goldman; Gunnar Sturfelt
Journal:  J Rheumatol       Date:  2002-05       Impact factor: 4.666

4.  Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual.

Authors:  G S Alarcón; G McGwin; A A Bartolucci; J Roseman; J Lisse; B J Fessler; H M Bastian; A W Friedman; J D Reveille
Journal:  Arthritis Rheum       Date:  2001-12

5.  Spanish cross-cultural adaptation and validation of the National Institutes of Health Stroke Scale.

Authors:  Raúl Domínguez; José F Vila; Federico Augustovski; Vilma Irazola; Pablo R Castillo; Roberto Rotta Escalante; Thomas G Brott; James F Meschia
Journal:  Mayo Clin Proc       Date:  2006-04       Impact factor: 7.616

6.  The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus.

Authors:  E M Hay; P A Bacon; C Gordon; D A Isenberg; P Maddison; M L Snaith; D P Symmons; N Viner; A Zoma
Journal:  Q J Med       Date:  1993-07

7.  Accrual of organ damage over time in patients with systemic lupus erythematosus.

Authors:  Dafna D Gladman; Murray B Urowitz; Proton Rahman; Dominique Ibañez; Lai-Shan Tam
Journal:  J Rheumatol       Date:  2003-09       Impact factor: 4.666

8.  The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics".

Authors:  Bernardo A Pons-Estel; Luis J Catoggio; Mario H Cardiel; Enrique R Soriano; Silvana Gentiletti; Antonio R Villa; Isaac Abadi; Francisco Caeiro; Alejandro Alvarellos; Donato Alarcón-Segovia
Journal:  Medicine (Baltimore)       Date:  2004-01       Impact factor: 1.889

9.  Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.

Authors:  D D Gladman; C H Goldsmith; M B Urowitz; P Bacon; C Bombardier; D Isenberg; K Kalunian; M H Liang; P Maddison; O Nived
Journal:  J Rheumatol       Date:  1994-08       Impact factor: 4.666

Review 10.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03
View more
  5 in total

1.  Development and initial validation of a self-assessed lupus organ damage instrument.

Authors:  Karen H Costenbader; Munther Khamashta; Silvia Ruiz-Garcia; Maria Teresa Perez-Rodriguez; Michelle Petri; Jennifer Elliott; Susan Manzi; Elizabeth W Karlson; Tabitha Turner-Stokes; Bonnie Bermas; Jonathan Coblyn; Elena Massarotti; Peter Schur; Patricia Fraser; Iris Navarro; John G Hanly; Timothy S Shaver; Robert S Katz; Eliza Chakravarty; Paul R Fortin; Martha L Sanchez; Jigna Liu; Kaleb Michaud; Graciela S Alarcón; Frederick Wolfe
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-04       Impact factor: 4.794

Review 2.  Pitfalls and opportunities in measuring patient outcomes in lupus.

Authors:  Meenakshi Jolly
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

3.  Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus.

Authors:  Jinoos Yazdany; Laura Trupin; Stuart A Gansky; Maria Dall'era; Edward H Yelin; Lindsey A Criswell; Patricia P Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-08       Impact factor: 4.794

Review 4.  Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI).

Authors:  Juanita Romero-Diaz; David Isenberg; Rosalind Ramsey-Goldman
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

Review 5.  Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues.

Authors:  Ashutosh M Shukla; Aparna Wagle Shukla
Journal:  Drugs Context       Date:  2019-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.